Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays.
Penn-Nicholson A, Gomathi SN, Ugarte-Gil C, Meaza A, Lavu E, Patel P, Choudhury B, Rodrigues C, Chadha S, Kazi M, Macé A, Nabeta P, Boehme C, Gangakhedkar RR, Sarin S, Tesfaye E, Gotuzzo E, du Cros P, Tripathy S, Ruhwald M, Singh M, Denkinger CM, Schumacher SG; Truenat Trial Consortium; Members of the Truenat Trial Consortium:. Penn-Nicholson A, et al. Eur Respir J. 2021 Nov 4;58(5):2100526. doi: 10.1183/13993003.00526-2021. Print 2021 Oct. Eur Respir J. 2021. PMID: 34049948 Free PMC article.
Design and pilot test of an implicit bias mitigation curriculum for clinicians.
Svetkey LP, Bennett GG, Reese B, Corsino L, Pinheiro SO, Fischer JE, Seidenstein J, Olsen MK, Brown T, Ezem N, Liu E, Majors A, Steinhauser KE, Sullivan BH, van Ryn M, Wilson SM, Yang H, Johnson KS. Svetkey LP, et al. Among authors: johnson ks. Front Med (Lausanne). 2024 Jun 6;11:1316475. doi: 10.3389/fmed.2024.1316475. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38903809 Free PMC article.
APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer's Disease.
Quiroz YT, Aguillon D, Aguirre-Acevedo DC, Vasquez D, Zuluaga Y, Baena AY, Madrigal L, Hincapié L, Sanchez JS, Langella S, Posada-Duque R, Littau JL, Villalba-Moreno ND, Vila-Castelar C, Ramirez Gomez L, Garcia G, Kaplan E, Rassi Vargas S, Ossa JA, Valderrama-Carmona P, Perez-Corredor P, Krasemann S, Glatzel M, Kosik KS, Johnson K, Sperling RA, Reiman EM, Sepulveda-Falla D, Lopera F, Arboleda-Velasquez JF. Quiroz YT, et al. Among authors: johnson k. N Engl J Med. 2024 Jun 20;390(23):2156-2164. doi: 10.1056/NEJMoa2308583. N Engl J Med. 2024. PMID: 38899694
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer.
Johnson KCC, Ni A, Quiroga D, Pariser AC, Sudheendra PK, Williams NO, Sardesai SD, Cherian M, Stover DG, Gatti-Mays M, Ramaswamy B, Lustberg M, Jhawar S, Skoracki R, Wesolowski R. Johnson KCC, et al. NPJ Breast Cancer. 2024 Jun 19;10(1):49. doi: 10.1038/s41523-024-00652-4. NPJ Breast Cancer. 2024. PMID: 38898072 Free PMC article.
Metabolism of New Drug Modalities Research Advances - 2023 year in review.
Ma B, Argikar U, Cheruzel L, Cho S, Hauri S, Johnson K, Liu J, Schadt S, Wang S, Khojasteh SC. Ma B, et al. Among authors: johnson k. Drug Metab Rev. 2024 Jun 19:1-46. doi: 10.1080/03602532.2024.2370331. Online ahead of print. Drug Metab Rev. 2024. PMID: 38895934 Review.
11,241 results
You have reached the last available page of results. Please see the User Guide for more information.